Research & Publications †
( † Disclaimer: This search is powered by PubMed, a service of the U.S. National Library of Medicine. PubMed is a third-party website with no affiliation with Cleveland Clinic.)
Peter A. Rasmussen, MD, is Director of the Cerebrovascular Center, Cleveland Clinic, and Associate Professor at Cleveland Clinic Lerner College of Medicine of Case Western Reserve University.
Dr. Rasmussen received his BS in biochemistry from the University of Wisconsin, Madison, in 1987. He earned his medical degree from the University of Wisconsin Medical School in 1991.
Peter Rasmussen, MD, has recently been appointed to president of the Board of Directors for the Society of NeuroInterventional Surgery. As president of the board Dr. Rasmussen will play a leading role on the national stage in continuing society initiatives to resource, train and support veteran and new practitioners in an area of medicine that is transforming treatment approaches to neurovascular conditions.
AVMs, brain aneurysm, carotid and intracranial angioplasty and stenting, Carotid Artery Disease, Carotid Artery Stenosis, Carotid Endarterectomy, Carotid Stenting, Cerebral Aneurysms, Cerebrovascular Disease, cerebrovascular disease including AVMs and intracranial aneurysms, dural AV fistulas, endovascular and microsurgical management of cerebral aneurysms, endovascular and microsurgical treatment of cerebral aneurysms and vascular malformations, endovascular treatment of stroke and intracranial occlusive disease, epistaxis, fistulas, Hemorrhagic Stroke, intracranial stenosis, ischemic stroke, pre-operative tumor embolization, spinal AVM's, spinal cord vascular malformations, spinal vascular malformations, stenting and surgical treatment of carotid disease, Stroke, treatment of spinal cord vascular lesions, vascular malformations
Cleveland Clinic physicians and scientists may collaborate with the pharmaceutical or medical device industries to help develop medical breakthroughs or provide medical education about recent trends. The collaborations are reviewed as part of the Cleveland
Clinic's procedures. The Cleveland Clinic publicly discloses payments to its physicians and scientists for speaking and consulting of $5,000 or more per year, and any equity, royalties, and fiduciary relationships in companies with which they collaborate. The Cleveland Clinic requires its doctors to approve the public disclosures of their scientific collaborations with industry. As of 8/31/2014 the review process regarding Dr. Rasmussen's disclosure had not been completed. Patients should feel free to contact their doctor about any of the relationships and how the relationships are overseen by the Cleveland Clinic. To learn more about the Cleveland Clinic's policies on collaborations with industry and innovation management, go to our Integrity in Innovation page.
Public Health Service-Reportable Financial Conflicts of Interest. Cleveland Clinic scientists and physicians engage in basic, translational and clinical research activities, working to solve health problems, enhance patient care and improve quality of life for patients. Interactions with industry are essential to bringing the researchers’ discoveries to the public, but can present the potential for conflicts of interest related to their research activities. Click here to view a listing of instances where Cleveland Clinic has identified a Public Health Service (PHS)-Reportable Financial Conflict of Interest and has put measures in place to ensure that, to the extent possible, the design, conduct and reporting of the research is free from bias.